None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Adult males from 20 to 64 years old at the time of giving consent. (2) Individuals whose fasting blood glucose values are from 110 to <126 mg/dL at the time of screening, or individuals whose postprandial blood glucose values at 120 min are from 140 to <200 mg/dL in 75 g OGTT at the screening. (3) Individuals who can make self-judgment to participate the study with their own will and can put signature and date to informed consent form by themselves prior to the study.
Exclusion criteria
Exclusion criteria: (1) Individuals who have serious medical history or have undergone resection surgery of digestive tract. (2) Individuals who have HbA1c (NGSP) values of 6.5 % or more. (3) Individuals continuously taking medication, FOSHU or health food product that may influence the results of this study. (4) Individuals who have allergies to Asteraceae plants and/or ingredients of the test foods or carbohydrate load. (5) Individuals with excessive alcohol drinking or heavy smoking. (6) Individuals judged as inappropriate for the study by the principal investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The area under the curve (AUC) of blood glucose (measured and variation from baseline) | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood glucose (measured), blood glucose Cmax (measured and variation from baseline), AUC of insulin (measured and variation from baseline), insulin (measured and variation from baseline), insulin Cmax (measured and variation from baseline) | — |
Countries
Japan
Contacts
Medical Corporation Hokubukai Utsukushigaoka Hospital Clinical Pharmacology Center